Clinical Trial Update: A Study of Flibanserin in Breast Cancer Survivors on Tamoxifen or Aromatase Inhibitors [Phase 2]

View source ↗

Summary

Phase 2 clinical trial evaluating flibanserin for hypoactive sexual desire disorder in breast cancer survivors on tamoxifen or aromatase inhibitors.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer
• Hypoactive Sexual Desire Disorder

Drugs mentioned

• Flibanserin (Flibanserin)

Snippet

Sponsor: Memorial Sloan Kettering Cancer Center | Conditions: Breast Cancer, Hyposexual Desire Disorder | Phase 2 | Status: ACTIVE_NOT_RECRUITING